Myelodysplastic syndromes: open trials in Denmark

10 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-11-06
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-11-04
NCT07384715
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
Trial Treatment · Phase 1 · Genmab
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe
Registry updated 2026-11-04
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-23
NCT05444348
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
Trial Treatment · Christoffer Johansen
Aalborg Universitetshospital, Aalborg · Aarhus Universitetshospital, Aarhus · Sydvestjysk sygehus - Esbjerg, Esbjerg · Regionshospitalet Gødstrup, Herning · Odense Universitetshospital, Odense · Sjællands Universitetshospital_Roskilde, Roskilde · Lillebælt syge - Vejle Sygehus, Vejle
Registry updated 2026-08-12
2024-511651-17-00
NMDSG-14B2
Trial Treatment · Phase 2 · Karolinska University Hospital
Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe
Registry updated 2026-05-27
NCT05693909
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
Trial Treatment · Phase 2 · Pharmacosmos A/S
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2025-09-24
NCT06773871
Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions
Trial Treatment · Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Copenhagen
Registry updated 2025-08-19
NCT04741945
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Trial Treatment · Phase 2 · Kirsten Grønbæk
Rigshospitalet, Copenhagen Oe
Registry updated 2024-11-22
NCT03999723
Combining Active and Passive DNA Hypomethylation
Trial Treatment · Phase 2 · Kirsten Grønbæk
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus · Herlev University Hospital, Copenhagen · Rigshospitalet, Copenhagen · Odense University Hospital, Odense · Zealand University Hospital, Roskilde
Registry updated 2024-04-17

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error